[1]
Matsuda, K.M. et al. 2021. Clinical Significance of Anti-U1 Ribonucleoprotein Antibody in Anti-Topoisomerase I Antibody-Positive Systemic Sclerosis Patients: A Retrospective Observational Study. Archives of Clinical and Biomedical Research. 5, 1 (Jan. 2021), 76–84.